Privia Health Group, Inc. (PRVA) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $1.26M; Additional Paid in CapitalUSD $925.26M; Retained Earnings (Accumulated Deficit)USD $-144.20M; Stockholders' Equity Attributable to ParentUSD $782.33M.
- 2026-03-31: Common Stock, Value, IssuedUSD $1.26M; Additional Paid in CapitalUSD $905.05M; Retained Earnings (Accumulated Deficit)USD $-153.25M; Stockholders' Equity Attributable to ParentUSD $753.06M.
- 2025-12-31: Common Stock, Value, IssuedUSD $1.24M; Additional Paid in CapitalUSD $892.29M; Retained Earnings (Accumulated Deficit)USD $-156.31M; Stockholders' Equity Attributable to ParentUSD $737.22M.
- 2025-09-30: Common Stock, Value, IssuedUSD $1.23M; Additional Paid in CapitalUSD $873.36M; Retained Earnings (Accumulated Deficit)USD $-165.46M; Stockholders' Equity Attributable to ParentUSD $709.12M.
Privia Health Group, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Noncontrolling Interest, Increase from Business Combination USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.26M | $925.26M | $-144.20M | $782.33M | $838.07M | 3 month · $19.40M | 3 month · $2.21M |
| 2026-03-31 | $1.26M | $905.05M | $-153.25M | $753.06M | $805.90M | 3 month · $21.92M | (m) |
| 2025-12-31 | $1.24M | $892.29M | $-156.31M | $737.22M | $790.94M | 12 month · $71.07M | (m) |
| 2025-09-30 | $1.23M | $873.36M | $-165.46M | $709.12M | $762.76M | 3 month · $18.98M | (m) |
| 2025-06-30 | $1.23M | $853.95M | $-172.32M | $682.86M | $733.55M | 3 month · $18.85M | (m) |
| 2025-03-31 | $1.21M | $833.23M | $-175.01M | $659.44M | $709.53M | 3 month · $17.79M | (m) |
| 2024-12-31 | $1.20M | $813.21M | $-179.23M | $635.18M | $683.45M | 12 month · $56.68M | 12 month · $1.65M |
| 2024-09-30 | $1.20M | $797.32M | $-183.63M | $614.89M | $662.18M | 3 month · $15.11M | 3 month · $653.00K |
| 2024-06-30 | $1.19M | $781.38M | $-187.16M | $595.41M | $643.61M | 3 month · $14.39M | 3 month · $1.00M |
| 2024-03-31 | $1.19M | $766.24M | $-190.63M | $576.80M | $622.82M | 3 month · $11.90M | (m) |
| 2023-12-31 | $1.18M | $753.87M | $-193.61M | $561.44M | $607.39M | 12 month · $37.10M | 12 month · $24.87M |
| 2023-09-30 | $1.18M | $739.95M | $-196.45M | $544.68M | $591.06M | 3 month · $10.80M | (m) |
| 2023-06-30 | $1.17M | $726.16M | $-202.09M | $525.23M | $571.31M | 3 month · $9.25M | 3 month · $569.00K |
| 2023-03-31 | $1.16M | $721.49M | $-209.37M | $513.28M | $556.52M | 3 month · $5.38M | 3 month · $24.21M |
| 2022-12-31 | $1.15M | $714.64M | $-216.69M | $499.09M | $519.05M | 12 month · $67.36M | 12 month · $125.00K |
| 2022-09-30 | $1.14M | $703.52M | $-234.47M | $470.19M | $491.07M | 3 month · $14.83M | (m) |
| 2022-06-30 | $1.10M | $680.15M | $-236.09M | $445.15M | $467.11M | 3 month · $18.47M | (m) |
| 2022-03-31 | $1.08M | $659.58M | $-225.62M | $435.04M | $457.90M | 3 month · $24.88M | 3 month · $125.00K |
| 2021-12-31 | $1.08M | $633.90M | $-208.11M | $426.87M | $450.18M | 12 month · $253.53M | 12 month · $28.82M |
| 2021-09-30 | $1.06M | $605.67M | $-196.13M | $410.60M | $405.00M | 3 month · $25.80M | (m) |
| 2021-06-30 | $1.06M | $579.26M | $-187.01M | $393.30M | $389.47M | 3 month · $202.56M | (m) |
| 2021-03-31 | $960.00K | $165.77M | $-14.48M | $152.25M | $149.37M | 3 month · $101.00K | (m) |
| 2020-12-31 | $960.00K | $165.67M | $-19.88M | $146.75M | $143.65M | 12 month · $484.00K | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | $135.05M | 3 month · $121.00K | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | $118.22M | 3 month · $121.00K | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | $112.91M | 3 month · $121.00K | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | $107.46M | 12 month · $207.00K | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | $86.04M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |